|
BAG4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.84610004850106E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.19939955137249E-10 |
| Normal-vs-Stage2 |
6.617900E-04 |
| Normal-vs-Stage3 |
3.067700E-02 |
| Normal-vs-Stage4 |
1.029960E-01 |
| Stage1-vs-Stage2 |
2.303400E-01 |
| Stage1-vs-Stage3 |
1.633750E-02 |
| Stage1-vs-Stage4 |
6.367600E-01 |
| Stage2-vs-Stage3 |
4.769200E-01 |
| Stage2-vs-Stage4 |
9.268000E-01 |
| Stage3-vs-Stage4 |
5.659200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.02340002928037E-09 |
| Normal-vs-AfricanAmerican |
1.07420000006186E-07 |
| Normal-vs-Asian |
1.339920E-03 |
| Caucasian-vs-AfricanAmerican |
9.287400E-01 |
| Caucasian-vs-Asian |
7.447000E-01 |
| AfricanAmerican-vs-Asian |
7.312800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.20550030963318E-10 |
| Normal-vs-Female |
1.659220E-03 |
| Male-vs-Female |
3.195300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.36639999995347E-06 |
| Normal-vs-Extreme_Weight |
2.99650304569354E-11 |
| Normal-vs-Obese |
5.88449999999741E-05 |
| Normal-vs-Extreme_Obese |
4.23179999999856E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.501400E-01 |
| Normal_Weight-vs-Obese |
2.284200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.245600E-01 |
| Extreme_Weight-vs-Obese |
7.799500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.095000E-01 |
| Obese-vs-Extreme_Obese |
3.232000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.045600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.5570000000984E-07 |
| Normal-vs-Age(61-80Yrs) |
4.60740001706483E-10 |
| Normal-vs-Age(81-100Yrs) |
7.28929999693761E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.274400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.861900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.704000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.620400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.150030E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.912180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.52210022363874E-10 |
| Normal-VS-Type2 PRCC |
1.497599999567E-07 |
| Normal-VS-KIRP CIMP |
4.659800E-01 |
| Normal-VS-Unclassified PRCC |
4.336900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.626400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.132300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.991800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.696400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.191800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.069600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.92620000347443E-09 |
| Normal-vs-N1 |
6.519200E-01 |
| Normal-vs-N2 |
6.716800E-01 |
| N0-vs-N1 |
5.451600E-02 |
| N0-vs-N2 |
5.218200E-01 |
| N1-vs-N2 |
8.401400E-01 |
|
|
